<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001845'>Inflammation</z:mp> plays an important role in ischemic pathology </plain></SENT>
<SENT sid="1" pm="."><plain>NF-κB is a transcription factor that has a crucial role in <z:mp ids='MP_0001845'>inflammation</z:mp> and cell survival, but its precise role in the ischemic aftermath is still uncertain </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, we evaluated the effect of intracerebroventricular administration of a highly specific NF-κB inhibitor <z:chebi fb="7" ids="16670">peptide</z:chebi>, IKK-NBD, on transient focal cerebral ischemic injury in rat using middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model </plain></SENT>
<SENT sid="3" pm="."><plain>The assessment of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-induced neurological deficits, alterations in the proinflammatory cytokine IL-1β level, OX-42 immunoreactivity, changes in blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) permeability, reactive oxygen species (ROS) production and DNA fragmentation by terminal <z:chebi fb="0" ids="17625">dUTP</z:chebi> nick end labelling (TUNEL) were monitored at 24h post reperfusion following 1h of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> after pre-treatment with either 40μg of IKK-NBD or the inactive IKK-NBD <z:chebi fb="7" ids="16670">peptide</z:chebi>, which served as control </plain></SENT>
<SENT sid="4" pm="."><plain>Pre-treatment with IKK-NBD <z:chebi fb="7" ids="16670">peptide</z:chebi> significantly ameliorated the <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-induced neurological deficits </plain></SENT>
<SENT sid="5" pm="."><plain>Quantification of IL-1β by ELISA revealed significantly reduced striatal IL-1β level in IKK-NBD <z:chebi fb="7" ids="16670">peptide</z:chebi> treated rats </plain></SENT>
<SENT sid="6" pm="."><plain>The treatment also resulted in reduced staining of microglial OX-42 and significantly reduced extravasation of Evans blue dye, indicating protection of <z:chebi fb="2" ids="33602">BBB</z:chebi> from ischemic insult </plain></SENT>
<SENT sid="7" pm="."><plain>These results indicate that specific NF-κB inhibition downplays post-ischemic <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, reduction in DNA fragmentation as assessed by TUNEL staining also confirms the neuroprotective effect of IKK-NBD <z:chebi fb="7" ids="16670">peptide</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, it may be inferred that IKK-NBD <z:chebi fb="7" ids="16670">peptide</z:chebi> reduces ischemic brain damage and this can, at least partly, be attributed to reduction in <z:mp ids='MP_0001845'>inflammation</z:mp> following ischemic injury </plain></SENT>
</text></document>